LIN-NEFAZODONE 100 MG
NEFAZODONE HYDROCHLORIDE : 100 MG · DIN 02237398 · LINSON PHARMA CO.
Health Canada status: CANCELLED POST MARKET
What is LIN-NEFAZODONE?
LIN-NEFAZODONE 100 MG contains NEFAZODONE HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02237398, held by LINSON PHARMA CO., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Nov-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02237398 |
|---|---|
| Brand name | LIN-NEFAZODONE |
| Generic / active ingredient | NEFAZODONE HYDROCHLORIDE : 100 MG |
| Manufacturer | LINSON PHARMA CO. |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AX06 NEFAZODONE |
| AHFS class | 28:16.04.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Nov-2003 |
| Original market date | 2000-09-11 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N06AX06 NEFAZODONE. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LIN-NEFAZODONE | 150 MG | TABLET | LINSON PHARMA CO. | CANCELLED POST MARKET | DIN 02237399 |
| LIN-NEFAZODONE | 200 MG | TABLET | LINSON PHARMA CO. | CANCELLED POST MARKET | DIN 02237400 |
| LIN-NEFAZODONE | 50 MG | TABLET | LINSON PHARMA CO. | CANCELLED POST MARKET | DIN 02237397 |
| SERZONE-5HT2 | 100 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02087375 |
| SERZONE-5HT2 | 150 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02087383 |
| SERZONE-5HT2 | 200 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02087391 |
| SERZONE-5HT2 | 50 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02087294 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.